Publications by authors named "David Royston"

Claim this Profile
U
Use and safety of aprotinin in routine clinical practice: A European postauthorisation safety study conducted in patients undergoing cardiac surgery.
Stefan De Hert, Alexandre Ouattara, David Royston, Jan van der Linden, Kai Zacharowski

Eur J Anaesthesiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiothoracic Anesthesia and Critical Care in the United Kingdom (UK) Part 1: Some Insights Into the History and Development.
David Royston, R Peter Alston

J Cardiothorac Vasc Anesth· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprotinin Relicense and Use of Nonapproved Interventions.
David Royston, Stefan De Hert, Alexandre Ouattara, Jan van der Linden, Kai Zacharowski

J Cardiothorac Vasc Anesth· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A special article following the relicence of aprotinin injection in Europe.
David Royston, Stefan De Hert, Jan van der Linden, Alexandre Ouattara, Kai Zacharowski

Anaesth Crit Care Pain Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tranexamic acid in cardiac surgery: is there a cause for concern?
David Royston

Crit Care· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprotinin and renal dysfunction.
Marie Bosman, David Royston

Expert Opin Drug Saf· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprotinin; an economy of truth?
David Royston

J Thorac Cardiovasc Surg· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of nitroglycerin-induced exhaled nitric oxide after lung transplantation: evidence of pulmonary microvascular injury?
Janos Gal, Tamas Kovesi, David Royston, Nándor Marczin

J Heart Lung Transplant· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.

Ann Thorac Surg· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of patients with perioperative myocardial infarction as diagnosed by troponin I after routine surgical coronary artery revascularization.
Bernhard J Riedel, Amanda Grattan, C Bruce Martin, Janos Gal, Andrew D Shaw, David Royston

J Cardiothorac Vasc Anesth· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
David Royston, Jerrold H Levy, Jane Fitch, Wulf Dietrich, Simon C Body

Anesth Analg· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
David Royston

Ann Thorac Surg· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety aspects of aprotinin therapy in cardiac surgery patients.
David Royston, Asha Chhatwani

Expert Opin Drug Saf· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between pulmonary gas exchange and basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) in patients undergoing cardiac surgery.
Tamás Kövesi, Anita Szabo, David Royston, Nándor Marczin

Vascul Pharmacol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparison and validity of troponin I assay systems in diagnosing myocardial ischemic injury after surgical coronary revascularization.
C Bruce Martin, Andrew D Shaw, Janos Gal, Natarajan Aravindan, Frank Murphy, David Royston

J Cardiothorac Vasc Anesth· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).
Victor A Ferraris, Suellen P Ferraris, David J Moliterno, Philip Camp, Jeanine M Walenga, David Royston

Ann Thorac Surg· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 1-2005: cardiac surgery in congenital afibrinogenemia with thrombo-occlusive disease.
Rosaleen Chun, Man-Chiu Poon, John Haigh, Doug Seal, Brian Donahue, David Royston

J Cardiothorac Vasc Anesth· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.
Bruce D Spiess, David Royston, Jerrold H Levy, Jane Fitch, Wulf Dietrich

Transfusion· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial.
Bernhard J Riedel, Janos Gal, Gillian Ellis, Paul J Marangos, Anthony W Fox, David Royston

Anesth Analg· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaesthesia: the patient's point of view.
David Royston, Felicia Cox

Lancet· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the role of serine protease inhibition in the management of tumor micrometastases.
Joe B Putnam, David Royston, Ann F Chambers, Scott Dunbar, John H Lemmer

Oncology (Williston Park)· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of remifentanil in coronary artery bypass graft surgery: a randomized, double-blind dose comparison study.
Ferd E A Geisler, Simon de Lange, David Royston, Roland Demeyere, David J R Duthie

J Cardiothorac Vasc Anesth· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The unwanted response to cardiac surgery: time for a reappraisal?
David Royston, Tomas Kovesi, Nandi Marczin

J Thorac Cardiovasc Surg· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Changes of exhaled nitrogen-monoxide concentration in acute ischemia-reperfusion injury of the lung].
Tamás Kövesi, David Royston, Magdi Yacoub, Erzsébet Röth, Nándor Marczin

Orv Hetil· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study.
Andrew Smith, Amanda Grattan, Mark Harper, David Royston, Bernhard J C J Riedel

J Cardiothorac Vasc Anesth· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis